SKK
DRTX

Shepherd Kaplan Krochuk’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,270
Closed -$165K – 666
2014
Q1 		$165K Sell
12,270
-7,077
-37% -$92.7K 0.02% 479
2013
Q4 		$247K Hold
19,347
– – 0.03% 379
2013
Q3 		$175K Hold
19,347
– – 0.03% 457
2013
Q2 		$139K Buy
+19,347
New +$142K 0.03% 487

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Shepherd Kaplan Krochuk's DRTX Position: Q2 2014 in Review

Shepherd Kaplan Krochuk sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q2 2014, closing a stake of 12,270 shares — an estimated $165K sold.

Shepherd Kaplan Krochuk first reported a position in DRTX in Q2 2013 and held it in 4 quarters. The position peaked at $247K in Q4 2013. 74 funds tracked by Wall St. Rank hold DRTX as of Q2 2014.

  • Shepherd Kaplan Krochuk reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 12,270 DURATA THERAPEUTICS INC COM STK (DE) shares in Q2 2014, an estimated $165K.
  • Shepherd Kaplan Krochuk first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • Shepherd Kaplan Krochuk's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $247K in Q4 2013.
  • 74 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q2 2014.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2014, filed 14 Aug 2014.